Hyundai Mobis Company will invest 1 trillion won more on research and development in 2020 to boost future revenues.
The South Korean auto parts manufacturer will undertake 2,000 R&D projects involving next-generation technologies, including autonomous vehicles, which is perceived as a driver of future growth.
Other key areas of R&D investment are powertrain electrification and environmentally-friendly solutions.
Earlier expansion plans were to boost the capacity to manufacture electric parts and to develop future vehicle technologies.
Hyundai Mobis also plans to increase its workforce to 5,000.
Overall, capital expenditure is expected to increase from 1.3 trillion won last year to 1.5 trillion won this year.
Hyundai Mobis is the largest component manufacturer in South Korea, with a turnover of 38,049 billion won mainly from sales of body and chassis systems to Kia and Hyundai.


Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Washington Post Publisher Will Lewis Steps Down After Layoffs
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 



